Enovis Cash Flow from Financial Activities 2010-2025 | ENOV

Enovis cash flow from financial activities from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
Enovis Annual Cash Flow Financial
(Millions of US $)
2024 $847
2023 $128
2022 $-465
2021 $585
2020 $-132
2019 $1,369
2018 $-47
2017 $-280
2016 $-145
2015 $-131
2014 $650
2013 $-45
2012 $2,183
2011 $33
2010 $-8
2009 $-5
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.551B $2.108B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.594B 60.55
Hims & Hers Health (HIMS) United States $12.830B 133.30
Doximity (DOCS) United States $11.392B 52.74
Tempus AI (TEM) United States $10.965B 0.00
IRhythm Technologies (IRTC) United States $4.223B 0.00
Inspire Medical Systems (INSP) United States $3.794B 59.28
Hinge Health (HNGE) United States $3.587B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.691B 0.00
Schrodinger (SDGR) United States $1.650B 0.00
Phreesia (PHR) United States $1.610B 0.00
Clover Health Investments (CLOV) United States $1.565B 0.00
Azenta (AZTA) United States $1.555B 72.25
Omnicell (OMCL) United States $1.318B 23.25
Evolent Health (EVH) United States $1.098B 93.50
Claritev (CTEV) United States $0.686B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Standard BioTools (LAB) United States $0.558B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Talkspace (TALK) United States $0.422B 126.00
TruBridge (TBRG) United States $0.349B 775.00
Outset Medical (OM) United States $0.312B 0.00
Health Catalyst (HCAT) United States $0.268B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.198B 0.00
Zepp Health (ZEPP) Netherlands $0.165B 0.00
KORU Medical Systems (KRMD) United States $0.162B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
EUDA Health Holdings (EUDA) Singapore $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.106B 0.00
CareCloud (CCLD) United States $0.100B 3.82
Insight Molecular Diagnostics (IMDX) United States $0.085B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.022B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00